Phase-1 Unit

September 4, 2022admin

Our cooperating phase I unit at Northwest Hospital in Frankfurt / University Cancer Center Frankfurt offers up to 12 in- or day-patient beds with full access to the intensive and emergency care units:

Welcome to the Phase 1 Unit, where we are dedicated to providing the highest quality of care to patients with cancer. In the Phase I unit, a therapy is applied to humans for the first time and its tolerability is investigated.
At our clinic, we understand that a cancer diagnosis can be overwhelming and frightening. Our team of highly skilled and experienced healthcare professionals is here to support you every step of the way. We will work collaboratively with you to develop a personalized treatment plan that addresses your specific needs and goals.
We are committed to advancing cancer research and offer our patients the opportunity to participate in clinical trials. By participating in these trials, you will have access to the latest cancer treatments before they are widely available.

Read More

team3

September 4, 2022admin

Staff

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

 

Our staff is dynamic, multidisciplinary and highly experienced. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, data managers, monitors (clinical research associates), statisticians, chemists, and others.

Team

PROF. DR. MED. SALAH-EDDIN AL-BATRAN

Founder and Managing Director of IKF

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

Our team embodies the following traits: clear communication, collaboration, open-mindedness, flexibility, accountability, trust, and service mentality. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, statisticians, chemists, and others.

With our multidisciplinary and highly specialized expertise, we bring a wealth of knowledge and diverse perspectives to problem-solving and decision-making.

PROF. DR. MED. SALAH-EDDIN AL-BATRAN

Founder and Managing Director of IKF

Over the years, our work has earned us an outstanding reputation in the field of oncology clinical trials. However, this is not solely a consequence of the ground-breaking scientific results we have achieved in close cooperation with our research partners. Above all, we owe our success to the extraordinary dedication, wisdom, and sense of responsibility of our employees.

Our team embodies the following traits: clear communication, collaboration, open-mindedness, flexibility, accountability, trust, and service mentality. The background of our employees often comprises a high degree (PhD) in medical or natural sciences. Beside medical professionals, our team comprises biologists, human biologists, bioinformaticians, statisticians, chemists, and others.

With our multidisciplinary and highly specialized expertise, we bring a wealth of knowledge and diverse perspectives to problem-solving and decision-making.

Read More

Service

September 4, 2022admin

We understand the importance of advancing science-driven research, and our commitment to our academic partners extends beyond financial considerations

Your Partner for Clinical Trials in Academia and Science-Driven Biotech

At IKF, we offer comprehensive clinical trial services tailored specifically for academia and science-driven biotech companies. Our clients benefit from our extensive oncology expertise and powerful international academic networks. As an institution founded by oncologists who have conducted their own trials, we understand the unique needs and challenges faced by academic groups when conducting clinical research.

We recognize that academic groups often operate within limited budgets and face financial risks associated with milestone-dependent payments. To address these concerns, IKF collaborates closely with academic groups and institutions on a risk-sharing basis. We work hand-in-hand with our academic partners, accompanying them throughout the entire clinical trial journey – from conceptualizing the idea to securing funding, conducting the trial, and publishing the results.

At IKF, we believe in supporting academic researchers in realizing their trial ideas. We actively engage in new initiatives and innovative approaches, and we do not hesitate to invest in these projects, even if fund-raising efforts are not immediately successful. We understand the importance of advancing science-driven research, and our commitment to our academic partners extends beyond financial considerations.

Comprehensive Research Organization Service

IKF has developed a high-quality full-service platform of experienced oncology professionals with specialized expertise in early phase and multidisciplinary trials and the commitment to providing personalized service and support clients throughout the trial process. Our services include but not limited to:

Read MoreRead Less

Data Management

Our data management focuses on quality control and data integrity of the clinical trial database – from database setup to database lock. We provide specification and development of user-friendly electronic case report forms (eCRFs) based on a well-structured database to ensure high-quality data for statistical analysis.

Read MoreRead Less

Statistics

Statistical parameters play an important role in ensuring the overall success of a clinical trial. Therefore, our statistics team is involved in the planning of any clinical trial from the very beginning and accompanies it through all trial stages, closely cooperating with the data management.

Read MoreRead Less

Read More

Own Research

September 4, 2022admin

Our “product” is the gain of scientific knowledge

Excellence in Research

Our research activities have a clear objective: to conduct and facilitate excellent clinical cancer research at the international level in order to improve the treatment and quality of life of cancer patients. As we are not a pharmaceutical company, our real “product” is the gain of scientific knowledge, which we achieve through clinical trials with our partners that focus on patient-relevant endpoints such as survival and quality of life.

Our trials have gained worldwide recognition for their significant impact on the field of cancer care

Investigator-initiated (non-pharma-sponsored) research

Sponsored by our institution and conducted on an international scale, our investigator-initiated trials result from collaborative efforts between our internal experts and external partners, including esteemed physicians and oncologists from various university hospitals.

Read MoreRead Less

We aim to accelerate the translation of research findings into tangible benefits for patients

Translational Research and IKF BioDataBank

We recognize the vital role of translational research in our study designs. We are dedicated to advancing our understanding of cancer pathogenesis and development, and to achieve this, we integrate translational elements into our research.

Read MoreRead Less

Precision oncology

We aim at improving personalized cancer therapy with our academic partners by establishing large networks and registries for molecular profiling. Our interactive PLATON Network (Platform for Analyzing Targetable Mutations) brings together comprehensive molecular profiling, extensive clinical data of cancer patients, QoL, education, and clinical trial information to advance cancer research and treatment.

Read MoreRead Less

Real-world studies

In addition to clinical trials, we conduct real-world studies in diverse healthcare settings. These studies provide valuable insights into the practical application of treatments, their effectiveness in routine care, and patient outcomes in real-world scenarios. By conducting research in real-life settings, we aim to bridge the gap between controlled clinical environments and the complexities of everyday clinical practice.

Read MoreRead Less

Read More

Linkedin Instagram Envelope

Frankfurter Institut für Klinische Krebsforschung IKF GmbH
Steinbacher Hohl 2-26
60488 Frankfurt am Main

Copyright © IKF GmbH 2024 all rights reserved